Trending Down-0.0018 (-3.9216%)
  • Bid / Lots
    0.0437/ 100
  • Ask / Lots
    0.0441/ 100
  • Open / Previous Close
    0.0458 / 0.0459
  • Day Range
    Low 0.0431
    High 0.0459
  • 52 Week Range
    Low 0.0220
    High 0.1049
  • Volume
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.0459
09:32 ET1090310.0459
09:33 ET35000.045
09:37 ET477760.0459
09:42 ET15240.0455
09:44 ET4210000.0442
09:50 ET207900.0441
09:51 ET1870000.0441
09:53 ET6102990.0439
09:55 ET1125000.0445
09:57 ET5000.0445
10:02 ET82000.0433
10:04 ET209500.0433
10:06 ET48910.0439
10:08 ET1000.0433
10:11 ET47860.04425
10:13 ET620000.044
10:20 ET1000.0445
10:22 ET87500.0445
10:24 ET62500.0445
10:33 ET200000.043785
10:36 ET930000.044
10:42 ET7910.044025
10:45 ET160230.044
10:47 ET2959770.0431
10:51 ET22000.0432
11:03 ET200000.0442
11:05 ET446690.0445
11:07 ET270000.0445
11:16 ET378320.0437
11:18 ET5000.0445
11:20 ET165000.04425
11:23 ET447500.0442
11:27 ET20000.04395
11:30 ET135660.04395
11:34 ET280000.04387
11:41 ET17000.0439
11:45 ET44470.0439
11:48 ET151000.04395
11:54 ET10000.044
11:57 ET1080.0438
11:59 ET220000.044
12:03 ET522930.044
12:10 ET211000.044025
12:14 ET39000.04395
12:15 ET5000.0441
12:17 ET1990.0441
12:24 ET15000.044025
12:28 ET400000.043905
12:30 ET310820.0438
12:33 ET1000000.0438
12:35 ET56680.0441
12:39 ET19200.0441
12:42 ET31650.0441
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesENZC
Enzolytics Inc
United StatesHOWL
Werewolf Therapeutics Inc
United StatesANIX
Anixa Biosciences Inc
United StatesATMS
Artemis Therapeutics Inc
United StatesMTNB
Matinas BioPharma Holdings Inc
United StatesEPIX
ESSA Pharma Inc
As of 2023-01-31

Company Information

Enzolytics, Inc. is a drug development biotechnology company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. The Company is focused on developing monoclonal antibody therapy and treating infectious diseases. It has anti-HIV therapeutics and a methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The Company has clinically tested anti-HIV therapeutics. The Company has developed a cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus. The Company has also created human cell lines that produce human antibodies against other infectious diseases, including rabies, influenza, tetanus, and diphtheria. The Company is testing these antibodies to prepare them for use as therapies against these diseases.

Contact Information

120 W Pomona AveMONROVIA, CA, United States 91016


No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.